HIV Prevention Review Meeting 2021

The successful HIV Prevention Review Meeting 2021 took place as a virtual meeting on 2 June 2021. The Program Directors would like to thank all invited speakers and participants for their contribution to this meeting! The next edition of this series, HIV Prevention Summit 2021 will take place from 1 - 2 December. For more information, please visit here: https://academicmedicaleducation.com/hiv-prevention-summit-2021 

The global HIV epidemic continues to present a significant health and economic burden for nearly 38 million infected people worldwide. Despite notable progress to contain the virus spread, and a reduction of nearly 40% in new infections in the last two decades, 1.7 million new cases were reported worldwide last year alone. This is particularly of concern in certain regions, where the number of new infections has been growing rapidly. In Eastern Europe, for instance, it has grown almost 50% per year since 2010.

HIV prevention is in the midst of an exciting chapter, with several different drugs and formulations being investigated or already available to prevent HIV acquisition. This wealth of new data and knowledge, being present at the major conferences, comes hand-in-hand with a need to review the importance of these findings and their implications for the implementation of prevention programs. The Prevention 2021 review meeting aims at bridging this gap to consolidate the implications of the new data presented at the last conferences, and thus extrapolates the impact of the latest emerging data.

General Information 

We trust that the following information (in alphabetical order) will assist you in organizing your participation in the HIV Prevention Review Program 2021.

The Program Directors are carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the meeting, and identify interesting topics and speakers.

The HIV Prevention Review Program 2021 is endorsed by the following societies and organizations. Their support and collaboration are key to the success of this program!

If you would like your organization to endorse this meeting, please contact Weixi Yuan at weixi@amededu.com. 

The HIV Prevention Review Meeting 2021, Utrecht (Livestream), Netherlands, 02/06/2021 - 02/06/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 2 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Please note that CME accreditation is only provided for delegates that attend the event livestream.

An online survey will be sent out to all attendees at the end of the meeting. After completing the survey, a CME certificate will be sent to your registration email. If you have any questions regarding claiming CME credits, please contact Weixi.Yuan@amededu.com. Please note that CME accreditation is only provided for delegates that attend the event livestream.

Mauro Schechter, MD, PhD

from Federal University of Rio de Janeiro

Susan Buchbinder, MD, PhD

from University of California, San Francisco / Bridge HIV, United States